PharmaCyte Biotech

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PMCB and other ETFs, options, and stocks.

About PMCB

PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. 

CEO
Kenneth L. Waggoner
CEOKenneth L. Waggoner
Employees
4
Employees4
Headquarters
Las Vegas, Nevada
HeadquartersLas Vegas, Nevada
Founded
1996
Founded1996
Employees
4
Employees4

PMCB Key Statistics

Market cap
52.71M
Market cap52.71M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
67.08K
Average volume67.08K
High today
$2.56
High today$2.56
Low today
$2.35
Low today$2.35
Open price
$2.44
Open price$2.44
Volume
122.66K
Volume122.66K
52 Week high
$3.40
52 Week high$3.40
52 Week low
$1.79
52 Week low$1.79

PMCB Earnings

-$0.64
-$0.43
-$0.21
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Estimated
per share
Estimated per share
Actual
-$0.07 per share
Actual-$0.07 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.